Renal Care Growth Target healthcare providers and dialysis clinics offering IDPN and IPN therapies under NutriRite brands, highlighting potential to expand uptake of precision nutrition and bundled medication services to improve patient outcomes.

Digital Community Leverage KidneyLyfe and TransplantLyfe platforms to create partnerships with patient networks, driving referrals, adherence programs, and co-branded education initiatives that increase patient engagement and clinic adoption.

Strategic Partnerships Explore collaborations with nephrology groups, hospitals, and patient advocacy organizations (e.g., Lyfebulb alignment) to expand clinical support services, nurse staffing resources, and continuing education for dietitians and nurses.

Clinical Evidence Emphasize published research on albumin improvements from IDPN and IPN therapies to support value-based purchasing, payer negotiations, and adoption of NutriRite therapy across middle-market renal care accounts.

Scale Opportunities Position bundled prescription medications and home infusion capabilities as a differentiator to healthcare systems seeking streamlined medication delivery, adherence, and remote patient monitoring in a growing renal nutrition market.